Hoʻāʻo ʻia ʻo NMPA no ka Molecular Candida Albicans i loko o 30 Min

ʻO Candida albicans (CA)ʻo ia ke ʻano pathogenic loa o nā ʻano Candida.1/3o ka vulvovaginitisnā hihia ai hoʻokumu ʻia e Candida, nona, KaleponiʻO ka maʻi he 80%. ʻO ka maʻi fungal,me CAʻo ka maʻi ma ke ʻano he laʻana maʻamau, he kumu nui ia o ka make mai ka maʻi haukapila. Ma waena o nā poʻe maʻi koʻikoʻi ma ka ICU,CAʻO ka maʻi he 40%. ʻO ka ʻike mua ʻana a me ka mālama ʻana i ka candidiasis pulmonary hiki ke hoʻomaikaʻi nui i ka prognosis o ka mea maʻi a hōʻemi i ka make.

Makro a me Miko-Hoʻāʻos ma ke koi ʻia wikiwiki a pololei hoʻiPahu ʻIke Waikawa Nucleic e pili ana i ka Enzymatic Probe Isothermal Amplification (EPIA) no Candida Albicans, meHoʻonui maʻalahi(ʻŌnaehana Hoʻonui Isothermal)hiki ke hōʻoia koke i ka ʻike a melāʻau antibiotic kokelāʻau lapaʻau.

•  Nā ʻano laʻana: Sputum a i ʻoleʻŌpū genitourinaryTʻokiʻokiSwab;
•  Ka Pono: Hoʻonui Isothermal me ka hopena i loko o 30 min;
•  ʻIke kiʻekiʻe: LoD o 100 baterial/mL;
•  Uhi ākea: Uhi ʻia ʻo Genotype A, B, C;
•  Hoʻohālikelike ākea: Me nā mea hana PCR fluorescence mainstream;

 ʻAmp maʻalahi: ʻO nā modula hana kūʻokoʻa 4x4 e hiki ai ke ʻike ma ke koi

Hana

	Laʻana o ka huʻa	ʻUwila no ke Ala Genitourinary
ʻIkepili	100.00%	100.00%
Kūlana kikoʻī	100.00%	100.00%
ʻORA	100.00%	100.00%